Understanding GLP-1 Agonists: The ‘Weight Loss’ Drugs Taking the World by Storm
Risk & Insurance - May 12, 2025
GLP-1 agonist drugs are designed to treat type 2 diabetes, but their secondary weight loss effect is driving popularity. The post Understanding GLP-1 Agonists: The ‘Weight Loss’ Drugs Taking the World by Storm appeared first on Risk & Insurance. ...
Recommended Articles
Posted: Jul 07, 2025
High-cost treatments and shifting demographics reshape risk profiles for employers and insurers, QBE...
Posted: Jul 06, 2025
As AI adoption accelerates in workers’ comp, claims executives face a pivotal challenge: how to harn...
Posted: Jul 02, 2025
The latest people news in the industry today. The post Nina Simons Appointed Global Head of MidCorp...